Modulation of Visually Evoked Potentials by an Antidepressant
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
12 normal healthy controls will be treated with 50 mg sertraline once daily for three weeks.
Early amplitudes of visually evoked potentials will be examined at day 0, 10 and 21 and
statistically compared. This study aims to examine a putative modulation of synaptic
transmission and plasticity by an antidepressant and is part of a series of studies in
healthy individuals and depressed patients.